Peripheral Blood and Skin Sample Collection for Cutaneous Lymphoma Research
18 Years
N/A
Both
Cutaneous T-cell Lymphoma, Sezary Syndrome, Mycosis Fungoides
Trial Information
Peripheral Blood and Skin Sample Collection for Cutaneous Lymphoma Research
The purpose of this study is to provide a central mechanism for monitoring access to
peripheral blood and skin specimens obtained from CTCL patients to monitor:
- immunologic assays/flow cytometry
- tumor progression/regression
- genomic studies
- proteomic studies
- others germane to the advancement of CTCL treatment
Inclusion Criteria:
- 18 or older
- able and willing to provide informed consent
- diagnosed with CTCL
Exclusion Criteria:
- Lack of CTCL diagnosis in medical record
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Outcome Measure:
Proteonomics of Cutaneous T-cell lymphoma
Outcome Description:
Proteonomic variables will be measured in blood and tissue of consented CTCL patients.
Outcome Time Frame:
Ongoing
Safety Issue:
No
Principal Investigator
Larisa J. Geskin, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Pittsburgh
Authority:
United States: Food and Drug Administration
Study ID:
0411029
NCT ID:
NCT00177268
Start Date:
October 2004
Completion Date:
January 2023
Related Keywords:
- Cutaneous T-cell Lymphoma
- Sezary Syndrome
- Mycosis Fungoides
- Cutaneous T-cell Lymphoma
- Sezary Syndrome
- Mycosis Fungoides
- Blood/tissue banking
- Lymphoma
- Mycoses
- Mycosis Fungoides
- Sezary Syndrome
- Lymphoma, T-Cell
- Lymphoma, T-Cell, Cutaneous
Name | Location |
|---|---|
| University of Pittsburgh Medical Center | Pittsburgh, Pennsylvania 15213 |
